OTCPK:MEDVF - Post by User
Post by
MrTAteamon Aug 17, 2020 7:45pm
183 Views
Post# 31420445
Spectral Analytics to Launch Patient Trial for
Spectral Analytics to Launch Patient Trial for COVID-19 Treatment.
"
A clinical research site has been selected and which will enroll 20 subjects in the initial study, with plans to expand the trial if the initial 20 subject trial demonstrates safety and efficacy in treating COVID-19. “This study is unique in that we have focused on identifying viruses that have similar characteristics, and are now exploring the potential of combining these drugs to create new effective treatments,” explained Steven Adler, CEO of Spectral Analytics. “The goal is to maximize the efficacy of the drugs in combating the virus, while minimizing the time required for testing, in order to rapidly get these drugs to those who need them most. Because these drugs are already FDA-approved for the treatment of other viruses, these drugs will also be more inexpensive to bring to market than newly-created drugs in a cost-effective manner for the patients.” https://www.einnews.com/pr_news/517296175/spectral-analytics-to-launch-patient-trial-for-covid-19-treatment